Microscopic Particles in Two Fractions of Fresh Cerebrospinal Fluid in Twins with Schizophrenia or Bipolar Disorder and in Healthy Controls

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Johansson, Viktoria ^a   Nybom, Rolf ^a   Wetterberg, Lennart ^a   Hultman, Christina M ^a   Cannon, Tyrone D ^b   Johansson, Anette G M ^a   Ekman, Carl Johan ^a   Landén, Mikael ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DIZYGOTIC TWINS; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MONOZYGOTIC TWINS; OUTCOME ASSESSMENT; PARTICLE SIZE; PREDICTION; RISK ASSESSMENT; SCANNING ELECTRON MICROSCOPY; SCHIZOPHRENIA; SYNDROME DELINEATION;

ADULT; BIPOLAR DISORDER; BODY MASS INDEX; CASE-CONTROL STUDIES; DISEASES IN TWINS; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; MODELS, NEUROLOGICAL; ODDS RATIO; POLYCARBOXYLATE CEMENT; REGRESSION ANALYSIS; SCHIZOPHRENIA; SWEDEN; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84866719350     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045994     Document Type: Article

References (33)

1. Schwarz E, Bahn S, (2008) Cerebrospinal fluid: identification of diagnostic markers for schizophrenia. Expert review of molecular diagnostics 8: 209-216.
2. Mattsson N, (2011) CSF biomarkers in neurodegenerative diseases. Clinical chemistry and laboratory medicine: CCLM/FESCC 49: 345-352.
3. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, et al. (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373: 234-239.
4. Wetterberg L, Nybom R, Bratlid T, Fladby T, Olsson B, et al. (2002) Micrometer-sized particles in cerebrospinal fluid (CSF) in patients with schizophrenia. Neuroscience letters 329: 91-95.
5. Ekelund J, Wahlbeck K, Back N, (2003) No association between micrometer-sized particles in human cerebrospinal fluid and schizophrenia. Neuroscience letters 349: 68-70.
6. Båve U, Nybom R, Landén M, Wetterberg L, (2010) Micrometer-sized thread-like and/or spherical particles in the first fraction of cerebrospinal fluid in patients with bipolar disorder. Bipolar disorders 12: 298-305.
7. Dalman C, Allebeck P, Gunnell D, Harrison G, Kristensson K, et al. (2008) Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. The American journal of psychiatry 165: 59-65.
8. Gupta S, Soellinger M, Grzybowski DM, Boesiger P, Biddiscombe J, et al. (2010) Cerebrospinal fluid dynamics in the human cranial subarachnoid space: an overlooked mediator of cerebral disease. I. Computational model. Journal of the Royal Society, Interface/the Royal Society 7: 1195-1204.
9. Lawrie SM, Olabi B, Hall J, McIntosh AM, (2011) Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World psychiatry: official journal of the World Psychiatric Association 10: 19-31.
10. Andersson C, Thunell S, Floderus Y, Forsell C, Lundin G, et al. (1995) Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods. Journal of internal medicine 237: 301-308.
11. Torgersen S, Onstad S, Skre I, Edvardsen J, Kringlen E, (1993) "True" schizotypal personality disorder: a study of co-twins and relatives of schizophrenic probands. The American journal of psychiatry 150: 1661-1667.
12. Hannelius U, Gherman L, Makela VV, Lindstedt A, Zucchelli M, et al. (2007) Large-scale zygosity testing using single nucleotide polymorphisms. Twin research and human genetics: the official journal of the International Society for Twin Studies 10: 604-625.
13. Spitzer RL, Williams JB, Gibbon M, First MB, (1992) The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of general psychiatry 49: 624-629.
14. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS (1997) Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.
15. Andreasen NC, (1984) The scale for the Assessment of Positive Symptoms (SAPS).
16. Andreasen NC, (1984) The scale for the Assessment of Positive Symptoms (SAPS).
17. Williams JB, (1988) A structured interview guide for the Hamilton Depression Rating Scale. Archives of general psychiatry 45: 742-747.
18. Young RC, Biggs JT, Ziegler VE, Meyer DA, (1978) A rating scale for mania: reliability, validity and sensitivity. The British journal of psychiatry: the journal of mental science 133: 429-435.
19. American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders: American Psychiatric Association.
20. Montgomery SA, Asberg M, (1979) A new depression scale designed to be sensitive to change. The British journal of psychiatry: the journal of mental science 134: 382-389.
21. Rydén E, Thase ME, Straht D, Aberg-Wistedt A, Bejerot S, et al. (2009) A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta psychiatrica Scandinavica 120: 239-246.
22. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, et al. (2003) Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological psychiatry 53: 1028-1042.
23. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of clinical psychiatry 59 (Suppl 20) (): 22-33;quiz 34-57.
24. Saunders J, Aasland O, Babor T, de la Fuente J, Grant M, (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 6: 791-804.
25. Berman AHBH, Palmstierna T, Schlyter F, (2005) Evaluation of the Drug Use Disorders Identification Test (DUDIT) in Criminal Justice and Detoxifi cation Settings and in a Swedish Population Sample. Eur Addict Res 1: 22-31.
26. Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, et al. (1993) Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. European neurology 33: 129-133.
27. Derr RE (2000) Performing Exact Logistic Regression with the SAS System. SAS Institute Inc., Cary, NC.
28. Reiber H, Felgenhauer K, (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clinica chimica acta; international journal of clinical chemistry 163: 319-328.
29. Bauer K, Kornhuber J, (1987) Blood-cerebrospinal fluid barrier in schizophrenic patients. European archives of psychiatry and neurological sciences 236: 257-259.
30. Kirch DG, Alexander RC, Suddath RL, Papadopoulos NM, Kaufmann CA, et al. (1992) Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia. Journal of neural transmission General section 89: 219-232.
31. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, et al. (2009) A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73: 1914-1922.
32. Bechter K, (2011) The peripheral cerebrospinal fluid outflow pathway- physiology and pathophysiology of CSF recirculation: A review and hypothesis. Neurology Psychiatry and Brain Research 17: 51-66.
33. Zachau AC, Landén M, Mobarrez F, Nybom R, Wallén H, et al. (2012) Leukocyte-derived microparticles and scanning electron microscopic structures in two fractions of fresh cerebrospinal fluid in amyotrophic lateral sclerosis; a case report. Journal of Medical Case Reports 6: 274 doi:10.1186/1752-1947-6-274.